Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - estriol, quantity: 1 mg/g - cream - excipient ingredients: sodium hydroxide; stearyl alcohol; lactic acid; cetyl esters wax; purified water; chlorhexidine hydrochloride; sorbitan monostearate; octyldodecanol; glycerol; polysorbate 60; cetyl alcohol - indications as at 18 december 2001. vulvo-vaginal complaints due to oestrogen deficiency associated with the climacteric and the postmenopause or after ovariectomy: atrophic vaginitis. puritis vulvae. dyspareunia due to vulvo-vaginal atrophy. as auxiliary therapy in the treatment of vaginal infections. as pre-operative therapy for vulvo-vaginal surgery and during subsequent convalescence. ulcers in the case of prolapse of the uterus or vagina. to avoid misinterpretation of a cytological smear.

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - pimecrolimus, quantity: 10 mg/g - cream - excipient ingredients: sodium hydroxide; citric acid; benzyl alcohol; sodium cetostearyl sulfate; mono- and di- glycerides; cetyl alcohol; stearyl alcohol; propylene glycol; oleyl alcohol; medium chain triglycerides; purified water - elidel 1% cream is indicated for patients 3 months of age and older with atopic dermatitis (eczema) for: short term treatment of signs and symptoms; intermittent long-term treatment of emerging and resolving lesions in atopic dermatitis where the use of a topical corticosteroid is not yet warranted, no longer needed, or is inadvisable (according to the usage restrictions in the respective topical corticosteroid product information).

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - betamethasone valerate, quantity: 0.24 mg/g (equivalent: betamethasone, qty 0.2 mg/g) - cream - excipient ingredients: cetomacrogol 1000; cetostearyl alcohol; white soft paraffin; liquid paraffin; purified water; chlorocresol; monobasic sodium phosphate; phosphoric acid; sodium hydroxide - indications as at 23 april 2004 : eczema includiing: atopic, infantile, stasis and discoid eczemas. besnier's (flexural) prurigo. otitis externa. neurodermatoses including lichen simplex, lichen planus. seborrheic dermatitis, contact sensitivity reactions and allergies.

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

pharmacare limited û woodmead - cream - see ingredients - each 1 g cream contains oestriol 1 mg

Ireland - English - HPRA (Health Products Regulatory Authority)

sofibel - bismuth oxide; balsam peru; zinc oxide - cream - 2.14/1.8/1 gram(s) - other agents for treatment of hemorrhoids and anal fissures for topical use; zinc preparations

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

ennogen healthcare ltd - lidocaine - cutaneous cream - 40mg/1gram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

colorama pharmaceuticals ltd - lidocaine - cutaneous cream - 40mg/1gram

Malta - English - Medicines Authority

pfizer hellas s.a. 243 messoghion ave., neo psychiko 15451, athens, greece - estrogens conjugated - cream - estrogens conjugated 0.625 mg/g - sex hormones and modulators of the genital system

Canada - English - Health Canada

pfizer canada ulc - conjugated estrogens - cream - 0.625mg - conjugated estrogens 0.625mg - estrogens

Singapore - English - HSA (Health Sciences Authority)

pfizer private limited - oestrogens (conjugated) - cream - 0.625 mg/g - oestrogens (conjugated) 0.625 mg/g